Sonoco Products Co. (SON) Financials Nov 17, 2014, 4:23

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Sonoco Products Co. (SON) Financials Nov 17, 2014, 4:23 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sonoco Products Co.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 3.6B 4.13B 4.5B 4.78B 4.84B
Cost of Goods Sold (COGS) incl. D&A 2.93B 3.35B 3.73B 3.93B 3.97B
COGS excluding D&A 2.76B 3.18B 3.55B 3.73B 3.77B
Depreciation & Amortization Expense 173.59M 169.67M 179.87M 200.4M 197.67M
Depreciation 161.18M 156.53M 163.2M 171.91M 169.4M
Amortization of Intangibles 12.41M 13.14M 16.67M 28.5M 28.27M
Gross Income 665.18M 780.15M 766.97M 851.41M 877.59M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 387.18M 403.49M 384.46M 464.09M 486.63M
Research & Development 12.39M 17.8M 18.84M 20.2M 20.1M
Other SG&A 374.79M 385.69M 365.63M 443.89M 466.53M
Other Operating Expense 0 0 0 0 0
Unusual Expense 25.29M 87.23M 60.03M 40.26M 25.82M
EBIT after Unusual Expense (25.29M) (87.23M) (60.03M) (40.26M) (25.82M)
Non Operating Income/Expense 0 0 0 0 (3.85M)
Non-Operating Interest Income 2.43M 2.31M 3.76M 4.13M 3.19M
Equity in Affiliates (Pretax) - - - - 0
Interest Expense 40.92M 37.29M 41.83M 64.11M 59.91M
Gross Interest Expense 40.92M 37.29M 41.83M 64.11M 65.86M
Interest Capitalized - 0 0 - 5.95M
Pretax Income 214.22M 254.45M 284.41M 287.07M 304.57M
Income Tax 66.82M 64.49M 78.42M 103.76M 96.2M
Income Tax - Current Domestic 27.93M 29.27M 33.83M 63.32M 34.9M
Income Tax - Current Foreign 17.2M 22.71M 34.79M 22.12M 25.09M
Income Tax - Deferred Domestic 18.52M 24.93M 41.24M 19.86M 38.02M
Income Tax - Deferred Foreign 3.17M (12.43M) (31.44M) (1.53M) (1.8M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 7.74M 11.51M 12.06M 12.81M 12.03M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 155.15M 201.47M 218.04M 196.12M 220.4M
Minority Interest Expense 3.66M 421,000 527,000 110,000 1.28M
Net Income 151.48M 201.05M 217.52M 196.01M 219.11M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 151.48M 201.05M 217.52M 196.01M 219.11M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 151.48M 201.05M 217.52M 196.01M 219.11M
EPS (Basic) 1.50 1.98 2.15 1.93 2.14
Basic Shares Outstanding 100.78M 101.6M 101.07M 101.8M 102.58M
EPS (Diluted) 1.50 1.96 2.13 1.91 2.12
Diluted Shares Outstanding 101.03M 102.54M 102.17M 102.57M 103.25M
EBITDA 451.59M 546.33M 562.38M 587.72M 588.63M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Qonto's Banking License Raises the Stakes in Europe

Updated Category News Views 46

A regulatory stamp can look dull on paper, yet this one changes the machinery underneath Qonto. The Paris-based finance platform has received a Credit Institution license from France's ACPR and the European Central Bank, giving it a route to offer broader lending and savings products directly to small and midsize businesses across Europe. That is a serious corporate...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 138

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge

Updated Category News Views 136

Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...

Continue Reading
Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 154

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
Bank of America AML Claims Put Controls Under Fire

Updated Category News Views 157

A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data

Updated Category News Views 152

Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 123

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 85

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 118

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading

Top 5 Most Recently Viewed Articles

Wicked Cutz, Cinnabon Team Up for Bacon Jerky Debut

Updated Category News Views 13

Ever thought you'd see the day when your protein snack could taste like a cinnamon roll? Well, folks, that day has arrived. Wicked Cutz, a force in the meat snack industry, and Cinnabon, the undisputed champs of cinnamon rolls, have rolled out a product that's bound to raise some eyebrows: bacon jerky with a sweet pastry twist. Why Bacon Jerky? You might be wondering, why...

Continue Reading
10 High-Yielding Small-Cap Stocks Under $15 in 2024

Updated Category Stocks Views 542

In the ever-evolving landscape of the stock market, small-cap stocks can be a gold mine for investors seeking high yields without breaking the bank. As we navigate through 2024, let's delve into a curated list of 10 small-cap stocks trading under $15 that offer attractive dividend yields. But remember, high yields can be as enticing as they are perilous, so tread with...

Continue Reading
Frazier Life Sciences Secures Over $630M for Growth Initiatives

Updated Category News Views 239

Frazier Life Sciences (FLS) raised over $630 million back in 2024, which got everyone buzzing on the trading floor. This wasn't just pocket change; it came from an oversubscribed fundraise that saw new and existing investors jumping on board like it was Black Friday. Talk about a cash infusion! The Public Fund has amassed around $1.7 billion since its launch three years...

Continue Reading
1847 Holdings LLC Achieves Milestone with $11.1M Offering

Updated Category News Views 112

1847 Holdings LLC Successfully Completes Public Offering 1847 Holdings LLC (NYSE American: EFSH), a company dedicated to investing in high-potential middle-market businesses, recently announced an exciting achievement. The firm has successfully closed its public offering, resulting in gross proceeds of $11.1 million. This accomplishment reflects the company's continued...

Continue Reading
Live Nation Entertainment's Stock Analysis Amid Sell-Off

Updated Category News Views 238

Understanding Live Nation Entertainment's Recent Stock Movements The trading landscape for Live Nation Entertainment, Inc. (LYV) has seen quieter activity following a significant sell-off of 6.5%. Investors and market analysts are closely observing whether this stock will continue its downward trajectory. Technical Analysis: Support and Resistance Levels Identifying Key...

Continue Reading